Results 61 to 70 of about 15,109,420 (166)

Non-Alcoholic Fatty Liver Disease

Proceedings of Singapore Healthcare, 2010
Non-alcoholic fatty liver disease (NAFLD) comprises a disease spectrum ranging from benign hepatic steatosis to non-alcoholic steatohepatitis with inflammation (NASH) and liver cirrhosis.
Hui-Hui Tan MRCP(UK), FAMS, Jason Pik-Eu Chang MMed (Int Med), MRCP(UK)   +1 more
doaj   +1 more source

Recent advances in understanding and managing non-alcoholic fatty liver disease [version 1; referees: 2 approved]

F1000Research, 2018
Non-alcoholic fatty liver disease is a leading cause of chronic liver disease that can lead to cirrhosis, hepatocellular cancer, and end-stage liver disease, and it is linked to elevated cardiovascular- and cancer-related morbidity and mortality. Insulin
Somaya Albhaisi, Arun Sanyal
doaj   +1 more source

A "systems medicine" approach to the study of non-alcoholic fatty liver disease

, 2015
The prevalence of fatty liver (steatosis) in the general population is rapidly increasing worldwide. The progress of knowledge in the physiopathology of fatty liver is based on the systems biology approach to studying the complex interactions among ...
Grieco, Antonio
core   +1 more source

Expression of resistin in the liver of patients with non-alcoholic fatty liver disease

, 2017
Adipokines are cytokines that presumably connect the pathologies of metabolic syndrome. One of the adipokines is resistin, the role of which in insulin resistance, obesity, and non-alcoholic fatty liver disease (NAFLD) needs to be determined.
Konrad Kobryń, Piotr Gierej, Rafał Paluszkiewicz, Bogna Ziarkiewicz-Wróblewska, Piotr Kalinowski, Beata Gierej, Tadeusz Wróblewski   +6 more
core   +1 more source

Association between non-high-density lipoprotein cholesterol and non-alcoholic fatty liver disease among people living with HIV on dolutegravir-based antiretroviral therapy: A cross-sectional study in Southwestern Uganda

BMC Research Notes
Objective Non-high-density lipoprotein cholesterol, an aggregate marker of atherogenic lipoproteins, has been implicated in metabolic dysfunction and may predict non-alcoholic fatty liver disease risk.
Charles Nkubi Bagenda, Carol Nantongo, Elastus Ssemwanga, Michael Junior Mugisa, Jesca Wafwoyo Akoth, Daniel Nzaramba, Rogers Kalyetsi, Elizabeth A. John, Jazira Tumusiime, Blendar Ainebyoona, Shadrach Omara, Vicent Mwesigye, Sylvia Achieng Lumumba, Conrad Lubwama, Benson Musinguzi, Lucas Ampaire, Rose Nassali, Herbert Itabangi, Lawrence Obado Osuwat, Brian Ssenkumba, Ronald Ouma Omolo   +20 more
doaj   +1 more source

FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism

Clinics, 2016
OBJECTIVE: This study was performed to evaluate the effects of metabolic parameters and thyroid dysfunction on the development of non-alcoholic fatty liver disease (NAFLD).
Fatma Yahyaoğlu Gökmen, Süleyman Ahbab, Hayriye Esra Ataoğlu, Betül Çavuşoğlu Türker, Faik Çetin, Fatih Türker, Rabia Yahyaoğlu Mamaç, Mustafa Yenigün   +7 more
doaj   +1 more source

Editor’s Pick: Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer? [PDF]

, 2015
Due to its increasing prevalence, exceeding 25% of the Western population, non-alcoholic fatty liver disease (NAFLD) merits recognition as one of the most frequent chronic liver diseases (CLD) and requires consideration of the associated disease-related ...
Benedetta Campana, Markus Heim, David Semela, Christine Bernsmeier   +3 more
core  

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis [PDF]

, 2010
Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin). The Enhanced Liver Fibrosis (ELF) test consists of an
Julie Parkes, Stefan Zeuzem, Herrmann, Eva, Friedrich-Rust, Mireen, William Rosenberg, Sarrazin, Christopher, Mireen Friedrich-Rust, Sarrazin, Christoph, Christoph Sarrazin, Parkes, Julie, Eva Herrmann, Rosenberg, William, Zeuzem, Stefan   +12 more
core   +2 more sources

Sex-specific effect of dietary fatty acids on non-alcoholic fatty liver disease

Frontiers in Nutrition
BackgroundNon-alcoholic fatty liver disease is the most common chronic hepatic disease worldwide. Dietary fatty acid is tightly associated with the development of non-alcoholic fatty liver disease but few large-scale and in-depth clinical researches have
Jianhua Chen, Zeqin Zhang, Yuning Pan, Jiejun Shi   +3 more
doaj   +1 more source

A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease [PDF]

Yu-Jie Jiang,1,2 Ye-Ming Cao,1 Yong-Bing Cao,1 Tian-Hua Yan,2 Cheng-Lin Jia,1 Ping He1 1Institute of Vascular Anomalies, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 200082, People’s Republic of China; 2Department of Basic Medicine and ...
Cao YB, Yan TH, Cao YM, Jia CL, Jiang YJ, He P   +5 more
core